Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Allocetra-OTS |
Trade Name | |
Synonyms | Allogeneic ex-vivo-treated PBMCs|Allocetra |
Drug Descriptions |
Allocetra-OTS is a cellular therapy comprising mononuclear cells induced to undergo early apoptosis, which potentially decreases tumor growth (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192805 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Allocetra-OTS | Allocetra-OTS | 0 | 1 |
Allocetra-OTS + Nivolumab | Allocetra-OTS Nivolumab | 0 | 1 |
Allocetra-OTS + Tislelizumab | Allocetra-OTS Tislelizumab | 0 | 1 |